Fresenius SE

Medicine & Research - 2003

23.09.2003Phase I/II study completed successfully: New antibody to treat ovarian cancer patients with symptomatic ascites (fluid accumulation in the abdominal cavity) shown to be well tolerated
PDF Text as PDF-file
17.06.2003Fresenius grants licence to market immunosuppressive agent ATG in North America
PDF Text as PDF-file
Home  >  Press  >  Press Releases  >  Medicine & Research  >  2003